Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2024

06.12.2023 | Gynecologic Oncology

Smooth muscle tumours of the uterus: MR imaging malignant predictive features—a 12-year analysis in a referral hospital in Portugal

verfasst von: Patrícia Freitas, Teresa Resende-Neves, Pedro Lameira, Marta Costa, Paulo Dias, Juliana Filipe, Joana Ferreira, Ana Félix, Teresa Margarida Cunha

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the magnetic resonance imaging (MRI) features that may help distinguish leiomyosarcomas from atypical leiomyomas (those presenting hyperintensity on T2-W images equal or superior to 50% compared to the myometrium).

Materials and methods

The authors conducted a retrospective single-centre study that included a total of 57 women diagnosed with smooth muscle tumour of the uterus, who were evaluated with pelvic MRI, between January 2009 and March 2020. All cases had a histologically proven diagnosis (31 Atypical Leiomyomas—ALM; 26 Leiomyosarcomas—LMS). The MRI features evaluated in this study included: age at presentation, dimension, contours, intra-tumoral haemorrhagic areas, T2-WI heterogeneity, T2-WI dark areas, flow voids, cyst areas, necrosis, restriction on diffusion-weighted imaging (DWI), apparent diffusion coefficient (ADC) values, signal intensity and heterogeneity after contrast administration in T1-WI, presence and location of unenhanced areas. The association between the MRI characteristics and the histological subtype was evaluated using Chi-Square and ANOVA tests.

Results

The MRI parameters that showed a statistically significance correlation with malignant histology and thus most strongly associated with LMS were found to be: irregular contours (p < 0.001), intra-tumoral haemorrhagic areas (p = 0.028), T2-WI dark areas (p = 0.016), high signal intensity after contrast administration (p = 0.005), necrosis (p = 0.001), central location for unenhanced areas (p = 0.026), and ADC value lower than 0.88 × 10−3 mm2/s (p = 0.002).

Conclusion

With our work, we demonstrate the presence of seven MRI features that are statistically significant in differentiating between LMS and ALM.
Literatur
1.
Zurück zum Zitat Arleo EK, Schwartz PE, Hui P, McCarthy S (2015) Review of leiomyoma variants. Am J Roentgenol 205(4):912–921CrossRef Arleo EK, Schwartz PE, Hui P, McCarthy S (2015) Review of leiomyoma variants. Am J Roentgenol 205(4):912–921CrossRef
3.
Zurück zum Zitat WHO Classification of Tumours Editorial Board, editor (2020) WHO Classification of Tumours. Female Genital Tumours. 5th ed. Vol. 4. 272–285 WHO Classification of Tumours Editorial Board, editor (2020) WHO Classification of Tumours. Female Genital Tumours. 5th ed. Vol. 4. 272–285
4.
Zurück zum Zitat Beyan E, Kanmaz AG, İnan AH, Karataşlı V, Tutar SO, Alan M, Töz E, Sancı M (2019) Evaluation of occult uterine leiomyosarcomas. Ginekol Pol 90(8):433–437CrossRefPubMed Beyan E, Kanmaz AG, İnan AH, Karataşlı V, Tutar SO, Alan M, Töz E, Sancı M (2019) Evaluation of occult uterine leiomyosarcomas. Ginekol Pol 90(8):433–437CrossRefPubMed
5.
Zurück zum Zitat Abdel Wahab C, Jannot AS, Bonaffini PA, Bourillon C, Cornou C, Lefrère-Belda MA, Bats AS, Thomassin-Naggara I, Bellucci A, Reinhold C, Fournier LS (2020) Diagnostic algorithm to differentiate benign atypical leiomyomas from malignant uterine sarcomas with diffusion-weighted MRI. Radiology 297(2):361–371CrossRefPubMed Abdel Wahab C, Jannot AS, Bonaffini PA, Bourillon C, Cornou C, Lefrère-Belda MA, Bats AS, Thomassin-Naggara I, Bellucci A, Reinhold C, Fournier LS (2020) Diagnostic algorithm to differentiate benign atypical leiomyomas from malignant uterine sarcomas with diffusion-weighted MRI. Radiology 297(2):361–371CrossRefPubMed
6.
Zurück zum Zitat Sousa FAE, Ferreira J, Cunha TM (2021) MR Imaging of uterine sarcomas: a comprehensive review with radiologic-pathologic correlation. Abdom Radiol 46:5687–5706CrossRef Sousa FAE, Ferreira J, Cunha TM (2021) MR Imaging of uterine sarcomas: a comprehensive review with radiologic-pathologic correlation. Abdom Radiol 46:5687–5706CrossRef
7.
Zurück zum Zitat Lucas R, Cunha TM (2019) Uterine sarcomas. Medical radiology. Springer Verlag, pp 209–224 Lucas R, Cunha TM (2019) Uterine sarcomas. Medical radiology. Springer Verlag, pp 209–224
8.
Zurück zum Zitat Stewart EA, Barbieri RL, Goff B, Falcone T, Levine D. Uterine fibroids (leiomyomas): differentiating fibroids from uterine sarcomas Section Editors Stewart EA, Barbieri RL, Goff B, Falcone T, Levine D. Uterine fibroids (leiomyomas): differentiating fibroids from uterine sarcomas Section Editors
9.
Zurück zum Zitat Rio G, Lima M, Gil R, Horta M, Cunha TM (2019) T2 hyperintense myometrial tumors: can MRI features differentiate leiomyomas from leiomyosarcomas? Abdom Radiol 44(10):3388–3397CrossRef Rio G, Lima M, Gil R, Horta M, Cunha TM (2019) T2 hyperintense myometrial tumors: can MRI features differentiate leiomyomas from leiomyosarcomas? Abdom Radiol 44(10):3388–3397CrossRef
10.
Zurück zum Zitat Kubik-Huch RA, Weston M, Nougaret S, Leonhardt H, Thomassin-Naggara I, Horta M, Cunha TM, Maciel C, Rockall A, Forstner R (2018) European Society of Urogenital Radiology (ESUR) guidelines: MR imaging of leiomyomas. Eur Radiol 28(8):3125–3137CrossRefPubMedPubMedCentral Kubik-Huch RA, Weston M, Nougaret S, Leonhardt H, Thomassin-Naggara I, Horta M, Cunha TM, Maciel C, Rockall A, Forstner R (2018) European Society of Urogenital Radiology (ESUR) guidelines: MR imaging of leiomyomas. Eur Radiol 28(8):3125–3137CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Nakagawa M, Nakaura T, Namimoto T, Iyama Y, Kidoh M, Hirata K, Nagayama Y, Yuki H, Oda S, Utsunomiya D, Yamashita Y (2019) Machine learning to differentiate T2-weighted hyperintense uterine leiomyomas from uterine sarcomas by utilizing multiparametric magnetic resonance quantitative imaging features. Acad Radiol 26(10):1390–1399CrossRefPubMed Nakagawa M, Nakaura T, Namimoto T, Iyama Y, Kidoh M, Hirata K, Nagayama Y, Yuki H, Oda S, Utsunomiya D, Yamashita Y (2019) Machine learning to differentiate T2-weighted hyperintense uterine leiomyomas from uterine sarcomas by utilizing multiparametric magnetic resonance quantitative imaging features. Acad Radiol 26(10):1390–1399CrossRefPubMed
12.
Zurück zum Zitat Suzuki A, Aoki M, Miyagawa C, Murakami K, Takaya H, Kotani Y, Nakai H, Matsumura N (2019) Differential diagnosis of uterine leiomyoma and uterine sarcoma using magnetic resonance images: a literature review. Healthcare 7(4):158CrossRefPubMedPubMedCentral Suzuki A, Aoki M, Miyagawa C, Murakami K, Takaya H, Kotani Y, Nakai H, Matsumura N (2019) Differential diagnosis of uterine leiomyoma and uterine sarcoma using magnetic resonance images: a literature review. Healthcare 7(4):158CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Libertini M, Hallin M, Thway K, Noujaim J, Benson C, van der Graaf W, Jones RL (2021) Gynecological sarcomas: molecular characteristics, behavior, and histology-driven therapy. Int J Surg Pathol 29:4–20CrossRefPubMed Libertini M, Hallin M, Thway K, Noujaim J, Benson C, van der Graaf W, Jones RL (2021) Gynecological sarcomas: molecular characteristics, behavior, and histology-driven therapy. Int J Surg Pathol 29:4–20CrossRefPubMed
15.
Zurück zum Zitat Lakhman Y, Veeraraghavan H, Chaim J, Feier D, Goldman DA, Moskowitz CS, Nougaret S, Sosa RE, Vargas HA, Soslow RA, Abu-Rustum NR, Hricak H, Sala E (2017) Differentiation of uterine leiomyosarcoma from atypical leiomyoma: diagnostic accuracy of qualitative MR imaging features and feasibility of texture analysis. Eur Radiol 27(7):2903–2915CrossRefPubMed Lakhman Y, Veeraraghavan H, Chaim J, Feier D, Goldman DA, Moskowitz CS, Nougaret S, Sosa RE, Vargas HA, Soslow RA, Abu-Rustum NR, Hricak H, Sala E (2017) Differentiation of uterine leiomyosarcoma from atypical leiomyoma: diagnostic accuracy of qualitative MR imaging features and feasibility of texture analysis. Eur Radiol 27(7):2903–2915CrossRefPubMed
17.
Zurück zum Zitat Thomassin-Naggara I, Dechoux S, Bonneau C, Morel A, Rouzier R, Carette MF, Daraï E, Bazot M (2013) How to differentiate benign from malignant myometrial tumours using MR imaging. Eur Radiol 23(8):2306–2314CrossRefPubMed Thomassin-Naggara I, Dechoux S, Bonneau C, Morel A, Rouzier R, Carette MF, Daraï E, Bazot M (2013) How to differentiate benign from malignant myometrial tumours using MR imaging. Eur Radiol 23(8):2306–2314CrossRefPubMed
18.
Zurück zum Zitat Sato K, Yuasa N, Fujita M, Fukushima Y (2014) Clinical application of diffusion-weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma. Am J Obstet Gynecol 210(4):368.e1-368.e8CrossRefPubMed Sato K, Yuasa N, Fujita M, Fukushima Y (2014) Clinical application of diffusion-weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma. Am J Obstet Gynecol 210(4):368.e1-368.e8CrossRefPubMed
19.
Zurück zum Zitat Jagannathan JP, Steiner A, Bay C, Eisenhauer E, Muto MG, George S, Fennessy FM (2021) Differentiating leiomyosarcoma from leiomyoma: in support of an MR imaging predictive scoring system. Abdom Radiol 46(10):4927–4935CrossRef Jagannathan JP, Steiner A, Bay C, Eisenhauer E, Muto MG, George S, Fennessy FM (2021) Differentiating leiomyosarcoma from leiomyoma: in support of an MR imaging predictive scoring system. Abdom Radiol 46(10):4927–4935CrossRef
20.
Zurück zum Zitat Smith J, Zawaideh JP, Sahin H, Freeman S, Bolton H, Addley HC (2021) Differentiating uterine sarcoma from leiomyoma: BET1T2 ER Check! Br J Radiol 94(1125):20201332CrossRefPubMedPubMedCentral Smith J, Zawaideh JP, Sahin H, Freeman S, Bolton H, Addley HC (2021) Differentiating uterine sarcoma from leiomyoma: BET1T2 ER Check! Br J Radiol 94(1125):20201332CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Santos P, Cunha TM (2015) Uterine sarcomas: clinical presentation and MRI features. Diagn Interv Radiol 21(1):4–9CrossRefPubMed Santos P, Cunha TM (2015) Uterine sarcomas: clinical presentation and MRI features. Diagn Interv Radiol 21(1):4–9CrossRefPubMed
23.
Zurück zum Zitat Brölmann H, Tanos V, Grimbizis G, Ind T, Philips K, van den Bosch T, Sawalhe S, van den Haak L, Jansen FW, Pijnenborg J, Taran FA, Brucker S, Wattiez A, Campo R, O’Donovan P, de Wilde RL (2015) Options on fibroid morcellation: a literature review. Gynecol Surg 12(1):3–15CrossRefPubMedPubMedCentral Brölmann H, Tanos V, Grimbizis G, Ind T, Philips K, van den Bosch T, Sawalhe S, van den Haak L, Jansen FW, Pijnenborg J, Taran FA, Brucker S, Wattiez A, Campo R, O’Donovan P, de Wilde RL (2015) Options on fibroid morcellation: a literature review. Gynecol Surg 12(1):3–15CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Matsuda M, Ichimura T, Kasai M, Murakami M, Kawamura N, Hayashi T, Sumi T (2014) Preoperative diagnosis of usual leiomyoma, atypical leiomyoma, and leiomyosarcoma. Sarcoma 2014:1–6CrossRef Matsuda M, Ichimura T, Kasai M, Murakami M, Kawamura N, Hayashi T, Sumi T (2014) Preoperative diagnosis of usual leiomyoma, atypical leiomyoma, and leiomyosarcoma. Sarcoma 2014:1–6CrossRef
25.
Zurück zum Zitat Pron G (2015) Magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) treatment of symptomatic uterine fibroids: an evidence-based analysis. Ont Health Technol Assess Ser 15(4):1–86PubMedPubMedCentral Pron G (2015) Magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) treatment of symptomatic uterine fibroids: an evidence-based analysis. Ont Health Technol Assess Ser 15(4):1–86PubMedPubMedCentral
26.
Zurück zum Zitat Pritts EA, Vanness DJ, Berek JS, Parker W, Feinberg R, Feinberg J, Olive DL (2015) The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis. Gynecol Surg 12(3):165–177CrossRefPubMedPubMedCentral Pritts EA, Vanness DJ, Berek JS, Parker W, Feinberg R, Feinberg J, Olive DL (2015) The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis. Gynecol Surg 12(3):165–177CrossRefPubMedPubMedCentral
Metadaten
Titel
Smooth muscle tumours of the uterus: MR imaging malignant predictive features—a 12-year analysis in a referral hospital in Portugal
verfasst von
Patrícia Freitas
Teresa Resende-Neves
Pedro Lameira
Marta Costa
Paulo Dias
Juliana Filipe
Joana Ferreira
Ana Félix
Teresa Margarida Cunha
Publikationsdatum
06.12.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2024
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-023-07294-0

Weitere Artikel der Ausgabe 4/2024

Archives of Gynecology and Obstetrics 4/2024 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.